Strata Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Buy
11,000
+639
+6% +$17K 0.08% 71
2025
Q4
$258K Sell
10,361
-277
-3% -$6.99K 0.07% 79
2025
Q3
$271K Sell
10,638
-54
-0.5% -$1.33K 0.07% 84
2025
Q2
$259K Buy
+10,692
New +$249K 0.07% 68
2025
Q1
Sell
-15,162
Closed -$402K 75
2024
Q4
$402K Buy
15,162
+3,897
+35% +$106K 0.13% 55
2024
Q3
$326K Buy
+11,265
New +$329K 0.1% 58

Other funds holding PFE

Strata Wealth Advisors's PFE Position: Q1 2026 in Review

Strata Wealth Advisors increased its Pfizer (PFE) stake by 6.2% in Q1 2026, buying an estimated $17K and bringing the position to 11,000 shares worth $309K. The position accounts for 0.08% of the portfolio, ranked #71.

Strata Wealth Advisors first reported a position in PFE in Q3 2024 and has held it in 6 quarters since. The position peaked at $402K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Strata Wealth Advisors held 11,000 shares of Pfizer worth $309K as of Q1 2026.
  • Strata Wealth Advisors bought 639 Pfizer shares in Q1 2026, an estimated $17K.
  • Pfizer made up 0.08% of Strata Wealth Advisors's portfolio in Q1 2026, its #71 holding.
  • Strata Wealth Advisors first reported a position in Pfizer in Q3 2024 and has held it in 6 quarters since.
  • Strata Wealth Advisors's Pfizer position peaked at $402K in Q4 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Strata Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.